Location History:
- Vedbæk, DK (2013 - 2017)
- Vedbaek, DK (2013 - 2018)
Company Filing History:
Years Active: 2013-2018
Title: Christine Andersen: Innovator in Pharmaceutical Composition
Introduction
Christine Andersen is a notable inventor based in Vedbaek, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release systems for opioids. With a total of 11 patents to her name, Andersen's work is recognized for its innovative approach to drug delivery.
Latest Patents
Among her latest patents is the "Morphine Controlled Release System." This oral pharmaceutical composition is designed for the controlled release of an opioid from a matrix composition. It includes an erodible matrix made from a mixture of polymers and an opioid, along with a coating that has openings exposing the matrix surface. This composition allows for a zero-order release profile, where approximately 75% of the opioid is released within 4-10 hours during dissolution testing. Another significant patent is the "Opioid Polymer Release System," which describes a pharmaceutical composition that releases an active substance into an aqueous medium through the erosion of the matrix surface. This innovative design also incorporates a coating and is aimed at enhancing the efficacy of drug delivery.
Career Highlights
Christine Andersen has established herself as a leading figure in her field through her work at Egalet Ltd. Her expertise in pharmaceutical formulations has led to advancements that address critical needs in pain management and opioid delivery systems.
Collaborations
Andersen has collaborated with notable colleagues, including Gina Engslev Fischer and Lillian Slot. These partnerships have contributed to the development of her innovative patents and have fostered a collaborative environment for research and development.
Conclusion
Christine Andersen's contributions to pharmaceutical innovations, particularly in controlled release systems, highlight her role as a key inventor in the industry. Her work continues to influence the field and improve patient outcomes through advanced drug delivery methods.